Histogen Gains Funding to Advance Biologic Knee Cartilage Regeneration
The $2 million grant will fund a Phase I/II clinical trial of HST-003 for regeneration of cartilage in the knee....
The $2 million grant will fund a Phase I/II clinical trial of HST-003 for regeneration of cartilage in the knee....
Financing will provide 7D with the capital to grow existing operations, further develop new products and continue its expansion into...
The round supports development and FDA 510(k) clearance for the LiveAlign system in 2021. The platform augments surgery with digital...
The company developed BioBrace material to augment and reinforce a range of tendon and ligament procedures, like rotator cuff repair...
As a strategic partner of Johnson & Johnson Medical, the entities have developed solutions for orthopedic joint digitization and intelligence....
Proceeds will drive ExsoMed's fracture repair products for the hand, including launches scheduled for late 2020 and early 2021. ...
The company will use the capital to support ongoing clinical trials of its injectable Discogenic Cell Therapy (IDCT) for lumbar...
The company raises the funds through a non-brokered private placement. The proceeds will fund initiatives like securing FDA approval for...
The $4 million round will support additional preclinical testing for the BioPrax device to eliminate biofilm infections on prosthetic joints....
Funds will support new product development and launch, including the recently FDA-cleared APEX 3D Total Ankle Replacement....
Login
Register for a free account
As a guest member you get access to more articles and videos every month.